John McNally is a clinical development leader at Corcept Therapeutics with over 15 years of biopharmaceutical experience. An alumnus of Dublin City University where he earned his PhD, he specializes in immunology and infectious diseases. He has a proven track record of successfully leading complex drug programs to global approval.
He played a pivotal leadership role in the global development and approval of novel therapies, including JYSELECA® for ulcerative colitis and EPCLUSA® for HCV infection.
Read the full overview →Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.